Introduction The preponderance of dementia among postmenopausal women compared
with same-age men and the female sex hormones neuroprotective properties support a …

Introduction Experimental and epidemiological studies suggest female sex hormones to
have long-lasting neuroprotective and anti-ageing properties. Surgically-induced …

Background Associations between endogenous estrogen exposure indicators and risk of
subtypes of dementia have been unclear. Methods Databases (PubMed, EMBASE and Web …

There is increasing evidence that menopausal changes can have an impact on women's
cognition and potentially, the future development of dementia. In particular, the role of …

CONTEXT: While recent studies suggest that exogenous estrogen treatment could help
reduce age-related cognitive decline and delay the onset of dementia, this has not been …

Background/aims Among other risk factors, the decline in estrogen concentrations during
menopause may compromise cognitive function. Whether early menopause (EM) is …

Dementia is a pandemic chronic non-communicable disease. 10 in 100 women above age
65 will be diagnosed with dementia, primarily Alzheimer's disease (AD). Apart from age and …

A severe impairment of cognitive function characterizes dementia. Mild cognitive impairment
represents a transition between normal cognition and dementia. The frequency of cognitive …

Background Sex difference exists in the prevalence of dementia and cognitive decline. The
impacts of sex-specific reproductive risk factors across the lifespan on the risk of dementia or …

We reviewed epidemiological and experimental studies of female gonadal hormone
replacement therapy (HRT) on cognitive function in post-menopausal women and carried …